- Home
- AXSM vs HESM Comparison
AXSM vs HESM Comparison
Compare AXSM & HESM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- HESM
- Stock Information
- Founded
- AXSM 2012
- HESM 2014
- Country
- AXSM United States
- HESM United States
- Employees
- AXSM N/A
- HESM N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- HESM Oil & Gas Production
- Sector
- AXSM Health Care
- HESM Energy
- Exchange
- AXSM Nasdaq
- HESM Nasdaq
- Market Cap
- AXSM 4.4B
- HESM 3.8B
- IPO Year
- AXSM 2015
- HESM N/A
- Fundamental
- Price
- AXSM $98.68
- HESM $36.82
- Analyst Decision
- AXSM Strong Buy
- HESM Buy
- Analyst Count
- AXSM 14
- HESM 3
- Target Price
- AXSM $124.93
- HESM $38.67
- AVG Volume (30 Days)
- AXSM 568.5K
- HESM 772.2K
- Earning Date
- AXSM 11-12-2024
- HESM 10-30-2024
- Dividend Yield
- AXSM N/A
- HESM 7.45%
- EPS Growth
- AXSM N/A
- HESM 16.31
- EPS
- AXSM N/A
- HESM 2.37
- Revenue
- AXSM $338,457,000.00
- HESM $1,456,100,000.00
- Revenue This Year
- AXSM $40.67
- HESM $12.64
- Revenue Next Year
- AXSM $69.27
- HESM $11.26
- P/E Ratio
- AXSM N/A
- HESM $15.55
- Revenue Growth
- AXSM 51.47
- HESM 11.43
- 52 Week Low
- AXSM $60.28
- HESM $30.08
- 52 Week High
- AXSM $105.00
- HESM $39.11
- Technical
- Relative Strength Index (RSI)
- AXSM 62.20
- HESM 63.46
- Support Level
- AXSM $90.86
- HESM $34.19
- Resistance Level
- AXSM $99.35
- HESM $35.56
- Average True Range (ATR)
- AXSM 4.10
- HESM 0.66
- MACD
- AXSM 0.53
- HESM 0.24
- Stochastic Oscillator
- AXSM 66.63
- HESM 90.69
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About HESM Hess Midstream LP Share
Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.